Atlas Capital Advisors LLC Biogen Inc. Transaction History

Atlas Capital Advisors LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $7,092 - $8,004	-28 Reduced 31.82%	60 $15.4 Million
Q1 2023 May 16, 2023	SELL	$256.56 - $292.34 $153,166 - $174,526	-597 Reduced 87.15%	88 $24.5 Million
Q4 2022 Feb 15, 2023	BUY	$252.44 - $306.72 $172,921 - $210,103	685 New	685 $190 Million
Q1 2022 May 11, 2022	SELL	$193.77 - $244.14 $27,709 - $34,912	-143 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$223.92 - $287.77 $345,060 - $443,453	-1,541 Reduced 91.51%	143 $34.3 Million
Q3 2021 Oct 28, 2021	BUY	$282.99 - $369.05 $476,555 - $621,480	1,684 New	1,684 $476,000
Q1 2021 May 10, 2021	SELL	$242.95 - $284.63 $141,396 - $165,654	-582 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $441,333 - $664,316	-1,868 Reduced 76.24%	582 $142,000
Q3 2020 Oct 23, 2020	SELL	$264.77 - $305.71 $698,198 - $806,157	-2,637 Reduced 51.84%	2,450 $695,000
Q2 2020 Jul 28, 2020	BUY	$258.66 - $342.55 $1.28 Million - $1.7 Million	4,957 Added 3813.08%	5,087 $1.36 Million
Q1 2020 May 04, 2020	BUY	$268.85 - $341.04 $34,950 - $44,335	130 New	130 $41,000
Q3 2019 Nov 01, 2019	SELL	$217.44 - $243.88 $176,126 - $197,542	-810 Closed	0 $0
Q2 2019 Jul 25, 2019	SELL	$219.29 - $241.72 $775,848 - $855,205	-3,538 Reduced 81.37%	810 $0
Q1 2019 Apr 29, 2019	BUY	$216.71 - $338.96 $934,236 - $1.46 Million	4,311 Added 11651.35%	4,348 $0
Q2 2018 Jul 30, 2018	SELL	$257.52 - $306.91 $6,695 - $7,979	-26 Reduced 41.27%	37 $0
Q1 2018 Apr 18, 2018	BUY	$260.13 - $367.91 $16,388 - $23,178	63 New	63 $0

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Atlas Capital Advisors LLC with notifications on news.